Lijuan Lei

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, First Affiliated Hospital of Jiangxi Medical College

发表论文 23 篇 · 总被引 132 次 · h-index 8

代表论文

• Antirheumatic drug leflunomide attenuates atherosclerosis by regulating lipid metabolism and endothelial dysfunction via DHODH/AMPK signaling pathway (2024 · International Journal of Biological Sciences · 被引 21)
• ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet–Fed ApoE −/− Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux (2024 · Arteriosclerosis Thrombosis and Vascular Biology · 被引 18)
• A pan-PPAR agonist E17241 ameliorates hyperglycemia and diabetic dyslipidemia in KKAy mice via up-regulating ABCA1 in islet, liver, and white adipose tissue (2024 · Biomedicine & Pharmacotherapy · 被引 15)
• SIRT1 Activator E1231 Alleviates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism (2023 · Current Issues in Molecular Biology · 被引 13)
• Trichostatin D as a Novel KLF2 Activator Attenuates TNFα-Induced Endothelial Inflammation (2022 · International Journal of Molecular Sciences · 被引 12)
• Secondary Metabolites Produced by the Dominant Fungus Eurotium cristatum in Liupao Tea and Their Hypolipidemic Activities by Regulating Liver Lipid Metabolism and Remodeling Gut Microbiota (2024 · Journal of Agricultural and Food Chemistry · 被引 11)